All In Biotech

Free tool

FAERS Monitor: Hercessi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761346 or its brand name (Hercessi, Trastuzumab-Strf). Reports on generic versions are filed under their own applications.

Reports

14

Serious

12

86% of reports

Hospitalization

6

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea7
  • nausea4
  • vomiting4
  • enterocolitis3
  • leukopenia3
  • neutropenia3
  • thrombocytopenia3
  • alopecia2
  • anaemia2
  • asthenia2
  • back pain2
  • drug eruption2
  • fatigue2
  • headache2
  • hepatic function abnormal2

Reports by year received

View as table
YearReports
20253
202611

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,145 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
enterocolitisSignal3781.1286.41,622
drug eruption2169.647.0188
leukopeniaSignal390.133.0183
hepatic function abnormal280.522.388
thrombocytopeniaSignal340.314.879
neutropeniaSignal333.112.265
diarrhoeaSignal716.39.688
anaemia215.84.415
alopecia215.34.214
back pain212.93.612
vomitingSignal412.85.633
asthenia28.02.26
nauseaSignal47.63.317
headache24.81.33
fatigue23.91.12

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.